Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Biochemistry and Biophysics

P-Glycoprotein, Expressed in Multidrug Resistant Cells, Is Not Responsible for Alterations in Membrane Fluidity or Membrane Potential

Claudina Alemán, Jean-Philippe Annereau, Xing-Jie Liang, Carol O. Cardarelli, Barbara Taylor, Jun Jie Yin, Adorjan Aszalos and Michael M. Gottesman
Claudina Alemán
Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, Maryland 20892-4254 [C. A., J-P. A., X-J. L., C. O. C., A. A., M. M. G.]; FACS Core Facility, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255 [B. T.]; and Instrumentation and Biophysics Branch, Center for Food Safety and Applied Nutrition, College Park, Maryland 20740-3835 [J. J. Y.]
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Philippe Annereau
Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, Maryland 20892-4254 [C. A., J-P. A., X-J. L., C. O. C., A. A., M. M. G.]; FACS Core Facility, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255 [B. T.]; and Instrumentation and Biophysics Branch, Center for Food Safety and Applied Nutrition, College Park, Maryland 20740-3835 [J. J. Y.]
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xing-Jie Liang
Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, Maryland 20892-4254 [C. A., J-P. A., X-J. L., C. O. C., A. A., M. M. G.]; FACS Core Facility, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255 [B. T.]; and Instrumentation and Biophysics Branch, Center for Food Safety and Applied Nutrition, College Park, Maryland 20740-3835 [J. J. Y.]
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carol O. Cardarelli
Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, Maryland 20892-4254 [C. A., J-P. A., X-J. L., C. O. C., A. A., M. M. G.]; FACS Core Facility, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255 [B. T.]; and Instrumentation and Biophysics Branch, Center for Food Safety and Applied Nutrition, College Park, Maryland 20740-3835 [J. J. Y.]
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Taylor
Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, Maryland 20892-4254 [C. A., J-P. A., X-J. L., C. O. C., A. A., M. M. G.]; FACS Core Facility, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255 [B. T.]; and Instrumentation and Biophysics Branch, Center for Food Safety and Applied Nutrition, College Park, Maryland 20740-3835 [J. J. Y.]
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Jie Yin
Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, Maryland 20892-4254 [C. A., J-P. A., X-J. L., C. O. C., A. A., M. M. G.]; FACS Core Facility, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255 [B. T.]; and Instrumentation and Biophysics Branch, Center for Food Safety and Applied Nutrition, College Park, Maryland 20740-3835 [J. J. Y.]
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adorjan Aszalos
Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, Maryland 20892-4254 [C. A., J-P. A., X-J. L., C. O. C., A. A., M. M. G.]; FACS Core Facility, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255 [B. T.]; and Instrumentation and Biophysics Branch, Center for Food Safety and Applied Nutrition, College Park, Maryland 20740-3835 [J. J. Y.]
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael M. Gottesman
Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, Maryland 20892-4254 [C. A., J-P. A., X-J. L., C. O. C., A. A., M. M. G.]; FACS Core Facility, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255 [B. T.]; and Instrumentation and Biophysics Branch, Center for Food Safety and Applied Nutrition, College Park, Maryland 20740-3835 [J. J. Y.]
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published June 2003
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Determination of the half-life of MDR1 mRNA in tet-repressible cells. A, demonstration of the linearity of the quantitative RT-PCR assay for the probes MDR1. Cp = −3.9 log10 (copy number) + 49.08. R2 = 0.9951. B, effect of tetracycline on MDR1 transcript of HeLa P-gpon cells. MDR primers match both endogenous mRNA and plasmid mRNA. MDR-3′UTR primers match only endogenous MDR1 transcripts. The time course was performed after addition of 2 μg/ml tetracycline. Decay of MDR1 was calculated at the steady state, from 4 h to 24 h. ΔCpt − ΔCpt = 0 = −0.3071.t +0.1746 R2 = 0.9116.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Determination of time needed to return P-gp expression on tet-repressible cells to basal levels. A, to assay P-gp function, the ability of P-gp to pump out rhodamine 123 was studied. FACS was used to measure accumulation of rhodamine 123. HeLa P-gpon cells were treated up to 4 days in 2 μg/ml tetracycline (+T). Controls used were cells grown in colchicine (colch) and cells grown in the absence of drugs (−T). B, P-gp expression was also measured in a FACS assay with MRK16 (a mAb against human P-gp). C, a Western blot was used to verify the decrease of P-gp expression observed in the FACS assay. C219, another mAb against P-gp, was used to detect P-gp on blots. As a control for loading, an antibody against GAPDH was used. Lanes 1–4 are cells treated with 2 μg/ml tetracycline for 1, 2, 3, and 4 days, respectively; bars, ±SD.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Tet-repressible cells are MDR as determined by colony forming assays. HeLa Tet-Off, the parental cells, (•) and HeLa MDR-Off cells with different treatments were assayed for resistance to increasing amounts of (A) colchicine, (B) doxorubicin, and (C) vinblastine. HeLa P-gpcol (▴) were cultured in colchicine, HeLa P-gpoff (□) were cultured in 2 μg/ml tetracycline for the 8–10-day cloning assay, and HeLa P-gpon (♦) were cultured in the absence of all drugs 4 days before the cloning assay. HeLa P-gpoff-t (▪) cells were cultured in 2 μg/ml tetracycline before the cloning assay; for the duration of the cloning assay, tetracycline was removed; bars, ±SD.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Membrane potential measured with oxonol. Membrane potential of P-gp-expressing, drug-selected cells, KB-V1 (Lane 2) and KB-A1 (Lane 4), tet-repressible cells, 77.1 P-gpon (Lane 6) and HeLa P-gpon (Lane 8), and the control cells not expressing P-gp, KB-3–1 (Lane 1), KB-A1rev (Lane 3), 77.1 P-gpoff (Lane 5), and HeLa P-gpoff (Lane 7). Membrane potential was measured by flow cytometry, using oxonol (150 nm) as a membrane potential sensing dye, as detailed in “Materials and Methods.” Results show typical fluorescence intensities of a series of measurements with the cells (5 × 105 cells/ml). Several measurements with cells grown separately gave similar fluorescence intensity relations and relative membrane potentials (n = 3).

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Determination of motional freedom of ESR probe 5-doxyl-SA in tet-repressible and drug-selected cells. Motional freedom, as expressed by the order parameter, S, determined with the ESR probe 5-doxyl-SA inserted into plasma membranes of cells. Experimental details, and calculation of the order parameter are described in “Materials and Methods.” KB-3-1 cells (Lane 1), KB-A1rev (Lane 5), HeLa P-gpoff (Lane 7), and 77.1 P-gpoff (Lane 9) are P-gp nonexpressing cells, whereas KB-8–5 (Lane 2), KB-C1 (Lane 3), KB-V1 (Lane 4), and KB-A1 (Lane 6) are drug-selected cells that express P-gp in increasing amounts. Tet-repressible cells expressing P-gp are HeLa P-gpon (Lane 8) and 77.1 P-gpon (Lane 10). Mean order parameters were calculated from results obtained with separately grown cell-cultures (n = 3–4). t tests indicate P < 0.05 (∗) for the KB-8–5 and KB-C1 pair (∗); KB-3-1 and KB-V1 (∗); KB-A1 and KB-A1rev (∗). There were no significant differences between HeLa and 77.1 P-gpoff versus P-gpon; bars, ±SD.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Polarization of TMA-DPH and AOSA probes in cells. A, polarization of the TMA-DPH fluorescence probe at the surface of the plasma membrane of cells. KB-3-1 (Lane 1), KB-A1rev (Lane 3), HeLa P-gpoff (Lane 5), and 77.1 P-gpoff (Lane 7) cells are P-gp-nonexpressing cells. KB-V1 (Lane 2) and KB-A1 (Lane 4) are drug-selected, and HeLa P-gpon (Lane 6) and 77.1 P-gpon (Lane 8) are the tet-repressible P-gp-expressing cells. Mean polarizations were calculated from results obtained with separately grown cells (n = 2) and several measurements with cells from the same culture (n = 4–6). Statistical analysis indicates significant differences, P < 0.05 between KB-3-1 and KB-V-1 cells, and between KB-A1rev and KB-A1 cells. However, there is no significant difference between 77.1 P-gpon and 77.1 P-gpoff cells, and between HeLa P-gpon and HeLa P-gpoff cells. B, polarization of the plasma membranes was determined by using AOSA probe that inserts in the membranes. KB-3-1 and KB-A1rev cells (Lanes 1 and 5) are P-gp nonexpressing, and KB-8-5, KB-C1, and KB-V1 (Lanes 2, 3, and 4, respectively) are P-gp-expressing cells. Mean polarization numbers were obtained from two independently grown cell cultures, and several measurements were made with each cultured cell population (n = 3–4). Statistical evaluation indicates that there is significant difference, P < 0.05, between KB-3-1 or KB-A1rev and KB-V-1 cells. Statistical differences between other cells are not significant at the level of P < 0.05. Experimental details and calculation of polarization, P, for both A and B are described in “Materials and Methods;” bars, ±SD.

  • Fig. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Membrane lipid packing as expressed by fluorescence intensity of Merocyanin 540 stained cells. Experimental details are given in “Materials and Methods.” KB-3-1 (Lane 1) is a P-gp-nonexpressing parental cell, and KB-8-5, KB-C1, and KB-V1 (Lanes 2, 3, and 4, respectively) are P-gp-expressing drug-selected cells. One typical result of several, obtained with separately grown cells, is shown (n = 3); bars, ±SD.

PreviousNext
Back to top
Cancer Research: 63 (12)
June 2003
Volume 63, Issue 12
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
P-Glycoprotein, Expressed in Multidrug Resistant Cells, Is Not Responsible for Alterations in Membrane Fluidity or Membrane Potential
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
P-Glycoprotein, Expressed in Multidrug Resistant Cells, Is Not Responsible for Alterations in Membrane Fluidity or Membrane Potential
Claudina Alemán, Jean-Philippe Annereau, Xing-Jie Liang, Carol O. Cardarelli, Barbara Taylor, Jun Jie Yin, Adorjan Aszalos and Michael M. Gottesman
Cancer Res June 15 2003 (63) (12) 3084-3091;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
P-Glycoprotein, Expressed in Multidrug Resistant Cells, Is Not Responsible for Alterations in Membrane Fluidity or Membrane Potential
Claudina Alemán, Jean-Philippe Annereau, Xing-Jie Liang, Carol O. Cardarelli, Barbara Taylor, Jun Jie Yin, Adorjan Aszalos and Michael M. Gottesman
Cancer Res June 15 2003 (63) (12) 3084-3091;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Decreased Repair Activities of 1,N6-Ethenoadenine and 3,N4-Ethenocytosine in Lung Adenocarcinoma Patients
  • Identification and Characterization of Signal Transducer and Activator of Transcription 3 Recruitment Sites within the Epidermal Growth Factor Receptor
  • A Novel Telomerase Template Antagonist (GRN163) as a Potential Anticancer Agent
Show more Biochemistry and Biophysics
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement